Has Lin Chen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $773 in general payments to Lin Chen, MD across 23 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lin Chen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lin Chen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lin Chen, MD

Cardiovascular Disease · Minneapolis, MNNPI 1205800240

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Biosense Webster, Inc. at 25.1% of the total. That places this record below the midpoint for cardiovascular disease clinicians in MN, where the typical reported total is $778.

$773in general payments, 2019–2025

Across 23 payments — averaging $33.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biosense Webster, Inc.$194
Cvrx, Inc.$173
Medtronic$144
Biotronik Inc.$104
Abbott$69
Grifols USA, LLC$34
plus $55 from 3 others

$395,755in research payments, 2019–2025

Across 43 payments — averaging $9203.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Irhythm Technologies, Inc.$396K

What the payments were for

Food & beverage$773100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biosense Webster, Inc.	4	$194
Cvrx, Inc.	2	$173
Medtronic	1	$144
Biotronik Inc.	7	$104
Abbott	5	$69
Grifols USA, LLC	1	$34
Boston Scientific	1	$24
Atricure, Inc.	1	$17
Vifor Pharma, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Barostim Neo System$147
Carto 3$105

How this compares

$773 in reported general payments places this provider in the 45th percentile of 451 cardiovascular disease providers in Minnesota.

See all cardiovascular disease providers in Minnesota →

Medicare billing

Part B allowed, 2024

$47,943

Medicare patients

949

Services billed

1,478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	152	$214,903
XareltoRivaroxaban	66	$83,279
Metoprolol Succinate	139	$2,648
Flecainide Acetate	46	$1,731
Diltiazem 24hr Er (Cd)Diltiazem Hcl	39	$1,617
Amiodarone Hcl	57	$1,174
Diltiazem 24hr ErDiltiazem Hcl	12	$698
Diltiazem 24hr Er (Xr)Diltiazem Hcl	13	$586
SotalolSotalol Hcl	20	$536
Lisinopril	34	$360
Atorvastatin Calcium	21	$221
Amlodipine Besylate	19	$193
Warfarin Sodium	11	$189
Furosemide	20	$157
Metoprolol Tartrate	17	$154

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Minneapolis

Jeffrey ChambersMinneapolis$3.2M
Markus MeyerMinneapolis$786K
Robert SchwartzMinneapolis$502K
Robert VantasselMinneapolis$493K
Nedaa SkeikMinneapolis$453K
Joao CavalcanteMinneapolis$384K
Inderjit AnandMinneapolis$384K
David HurrellMinneapolis$205K
Yader Sandoval PichardoMinneapolis$157K
Charles HerzogMinneapolis$157K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →